Showing 1 - 3 results of 3 for search 'V. Kvikstad', query time: 0.02s Refine Results
  1. 1
    Pathological T1 substaging corresponds with BCG-failure and improves the current EAU risk stratification for non-muscle invasive bladder cancer patients

    Pathological T1 substaging corresponds with BCG-failure and improves the current EAU risk stratification for non-muscle invasive bladder cancer patients by F.C. De Jong, R. Hoedemaeker, V. Kvikstad, J.T. Mensink, E.R. Boevé, D.K.E. Van Der Schoot, J.L. Boormans, E.C. Zwarthoff, T.C.M. Zuiverloon

    Published 2020-07-01
    Get full text
    Article
  2. 2
    Definitions of BCG-failure (EAU) vs BCG-unresponsive (FDA) in high-risk non-muscle invasive bladder cancer: A comparison of patient outcome

    Definitions of BCG-failure (EAU) vs BCG-unresponsive (FDA) in high-risk non-muscle invasive bladder cancer: A comparison of patient outcome by F.C. De Jong, R.F. Hoedemaeker, V. Kvikstad, J.T.M. Mensink, E.R. Boevé, D.K.E. Van Der Schoot, J.L. Boormans, E.C. Zwarthoff, T.C.M. Zuiverloon

    Published 2020-07-01
    Get full text
    Article
  3. 3
    PD-L1 expression does not predict BCG-failure in a large cohort of high-risk non-muscle invasive bladder cancer patients

    PD-L1 expression does not predict BCG-failure in a large cohort of high-risk non-muscle invasive bladder cancer patients by F.C. De Jong, R.F. Hoedemaeker, A.M. Van Der Made, V. Kvikstad, T.P.P. Van Den Bosch, E.R. Boevé, D.K.E. Van Der Schoot, J.L. Boormans, E.C. Zwarthoff, T.C.M. Zuiverloon

    Published 2020-07-01
    Get full text
    Article

Search Tools: